Litcius/Paper detail

Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial

Mohammad Taghi Ashoobi, Hossein Hemmati, Hamid Reza Aghayan, Zeinab Zarei‐Behjani, Samaneh Keshavarz, Hamideh Babaloo, Saman Maroufizadeh, Saeed Yousefi, Mohaya Farzin, Elham Vojoudi

2023Cell and Tissue Research14 citationsDOI

Topics & Concepts

MedicineCritical limb ischemiaTransplantationMesenchymal stem cellSurgeryAmputationClinical trialAdverse effectRevascularizationInternal medicineVascular diseaseMyocardial infarctionPathologyArterial diseasePeripheral Artery Disease ManagementAngiogenesis and VEGF in CancerDiabetic Foot Ulcer Assessment and Management
Wharton’s jelly mesenchymal stem cells transplantation for critical limb ischemia in patients with type 2 diabetes mellitus: a preliminary report of phase I clinical trial | Litcius